The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records-Reference-Cited by-同舟云学术

The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records

Published:2019-03-04 Issue:5 Volume:22 Page:421-429
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Jamil Khurram¹,Huang Xingyue¹,Lovelace Belinda²,Pham An T²³,Lodaya Kunal⁴,Wan George¹

Affiliation:

1. Mallinckrodt Pharmaceuticals, Inc, Bedminster, NJ, USA;

2. Formerly of Mallinckrodt Pharmaceuticals, Inc, Bedminster, NJ, USA;

3. University of Washington School of Pharmacy, Seattle, WA, USA;

4. Boston Strategic Partners, Inc Health Economics and Outcomes Research, Boston, MA, USA

Funder

Mallinckrodt Pharmaceuticals, Inc.

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1580201

Reference29 articles.

1. Acute Kidney Injury in Patients with Cirrhosis

2. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement

3. Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study

4. US Department of Health and Human Services CfDCaP, National Center for Health Statistics. Summary Health Statistics: National Health Survey, 2015. National Center for Health Statistics: Centers for Disease Control and Prevention; 2015.

5. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing resuscitation in burn patients with varying degrees of liver disease;Burns;2024-05

2. Hepatorenal Syndrome;The Korean Journal of Gastroenterology;2023-11-25

3. Cost-effectiveness of terlipressin for hepatorenal syndrome: the United States hospital perspective;Journal of Medical Economics;2023-11-14

5. Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older;Annals of Hepatology;2023-09